22
Participants
Start Date
December 31, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
June 30, 2011
Rexin-G Dose 1
Rexin-G i.v., 1 x 10e11 cfu, two times a week x 4 weeks, rest 2 weeks May be repeated if grade 1 or less toxicity
Rexin-G Dose 2
Rexin-G i.v., 1 x 10e11 cfu, three times a week x 4 weeks; rest 2 weeks May repeated if grade 1 or less toxicity
Epeius Clinical Research Unit/Sarcoma Oncology Center, Los Angeles
Lead Sponsor
Epeius Biotechnologies
INDUSTRY